TAL1 and acute lymphoblastic leukemia: These results not only establish the functional role of the TAL1 oncogenic SE in promoting T-ALL development, but also demonstrate the efficacy of enCRISPRa and enCRISPRi for allele-specific perturbation of disease-associated enhancers in situ and in vivo.